Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

VolitionRX Limited Common Stock (VNRX)

In Vitro & In Vivo Diagnostic Substances

https://www.volition.com

VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

1489 WEST WARM SPRINGS ROAD, SUITE 110
HENDERSON, NV

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/25/2007

Market Cap

53,814,906

Shares Outstanding

78,690,000

Weighted SO

78,685,873

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

ECOR --.--%

CFMS --.--%

EVGN --.--%

EOLS --.--%

OCX --.--%

Beta

1.1390

Last Div

0.0000

Range

0.43-1.38

Chg

0.0143

Avg Vol

120762

Mkt Cap

53814906

Exch

AMEX

Country

US

Phone

646 650 1351

DCF Diff

1.0946

DCF

-0.3746

Div Yield

0.0000

P/S

55.1091

EV Multiple

-1.7123

P/FV

-2.2149

Div Yield %

0.0000

P/E

-1.4899

PEG

-0.1639

Payout

0.0000

Current Ratio

0.2371

Quick Ratio

0.2371

Cash Ratio

0.1937

DSO

62.1450

DIO

0.0000

Op Cycle

62.1450

DPO

891.2567

CCC

-829.1117

Gross Margin

-0.4042

Op Margin

-33.5566

Pretax Margin

-33.5735

Net Margin

-33.2012

Eff Tax Rate

0.0094

ROA

-2.4810

ROE

2.7442

ROCE

1.8299

NI/EBT

0.9889

EBT/EBIT

1.0005

EBIT/Rev

-33.5566

Debt Ratio

0.3938

D/E

-0.2360

LT Debt/Cap

-0.2154

Total Debt/Cap

-0.3089

Int Coverage

-303.3282

CF/Debt

-3.2807

Equity Multi

-0.5992

Rec Turnover

5.8734

Pay Turnover

0.4095

Inv Turnover

0.0000

FA Turnover

0.1811

Asset Turnover

0.0747

OCF/Share

-0.2042

FCF/Share

-0.2141

Cash/Share

0.0726

OCF/Sales

-17.2896

FCF/OCF

1.0483

CF Coverage

-3.2807

ST Coverage

-13.1804

CapEx Coverage

-20.6991

Div&CapEx Cov

-20.6991

P/BV

-2.2149

P/B

-2.2149

P/S

55.1091

P/E

-1.4899

P/FCF

-3.0405

P/OCF

-2.8610

P/CF

-2.8610

PEG

-0.1639

P/S

55.1091

EV Multiple

-1.7123

P/FV

-2.2149

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation